Abstract:The successful implementation of stem cell therapy requires the development of imaging techniques to track transplanted stem cells in vivo and monitor their fate over time. Most in vivo imaging methods focus on providing information about the distribution and migration of transplanted stem cells, while monitoring their viability-crucial for optimizing therapy-remains undeveloped. Although a few in vivo imaging techniques have been developed for assessing the viability of transplanted stem cells, their applicability is restricted by limited penetration depth. To address this, magnetic resonance imaging (MRI) that is collaboratively utilized with tailored contrast agents has been explored to track the viability of transplanted stem cells without this limitation. However, currently available MRI contrast agents struggle with low accuracy in monitoring viability due to poor controllability or minimal signal change in response to cell death. Here, we present an extremely small iron oxide nanoparticles (ESIONPs)-based T1-T2 switchable MRI contrast agent (ESIONPs-GSH) designed to accurately detect cell apoptosis in response to elevated reactive oxygen species (ROS).Specifically, ESIONPs-GSH was obtained by modifying the surface of ESIONPs with ROS-sensitive glutathione (GSH) and amphipathic 3-((3-aminopropyl) dimethylammonio) propane-1-sulfonate (ADPS) molecules. The results demonstrate that ESIONPs-GSH is biocompatible, with negligible effects on the proliferation and differentiation of bone mesenchymal stem cells (BMSCs) post-labeling. Additionally, BMSCs labeled with ESIONPs-GSH exhibit T1 contrast; upon cell death, increasing cellular ROS oxidize GSH and induce cross-linking of ESIONPs-GSH, resulting in a switch to T2 contrast. Benefiting from the significantly contrasting signal following the T1-T2 contrast switch, ESIONPs-GSH allows for accurate assessment of the survival of BMSCs transplanted into the axillary regions of mice through MRI monitoring. ESIONPs-GSH enabled MRI can effectively track transplanted stem cell viability in vivo without penetration depth limitations, making it a promising tool for guiding stem cell-based therapies.

In Vivo Stem Cell Imaging

Noninvasive in-vivo tracing and imaging of transplanted stem cells for liver regeneration.

Multimodality Molecular Imaging of Stem Cells Therapy for Stroke.

Molecular imaging for In vivo tracking of stem cell fate

Optical and MRI Multimodal Tracing of Stem Cells In Vivo

The Application of In Vivo Optical Imaging Technologies with Bioluminescence and Fluorescence on the Research of Stem Cell

In Vivo Cellular Imaging for Translational Medical Research.

Progress of Stem Cell Therapy of Cardiovascular Disease in Vivo Imaging Tracking

Revealing the Fate of Transplanted Stem Cells In Vivo with a Novel Optical Imaging Strategy.

Noninvasive strategies of cell-tracking in vivo

Assessing in Vitro Stem‐cell Function and Tracking Engraftment of Stem Cells in Ischaemic Hearts by Using Novel Irfp Gene Labelling

Stem Cell Tracking with Optically Active Nanoparticles.

Application of Molecular Imaging in Stem Cell Therapy for Ischemic Heart Diseases

Stem Cell Tracking Technologies for Neurological Regenerative Medicine Purposes

Tracking Neural Stem Cells in vivo: Achievements and Limitations

In Vivo Photoacoustic Monitoring of Stem Cell Location and Apoptosis with Caspase-3-Responsive Nanosensors

Positron emission tomography probes for stem cell monitoring: a review

In Vivo MRI Tracking of Bone Mesenchymal Stem Cell Viability with a T1-T2 Switchable Contrast Agent

Imaging: guiding the clinical translation of cardiac stem cell therapy.

Research progress in the molecular imaging tracking of cancer stem cells in vivo

Tracking of Stem Cells in Chronic Liver Diseases: Current Trends and Developments.